Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,900 | -2,730 | -3,010 | -3,350 | -7,670 |
| Depreciation Amortization | 60 | 50 | 100 | 190 | 1,250 |
| Other Working Capital | 210 | -240 | 140 | -310 | 60 |
| Other Operating Activity | 160 | 250 | 410 | 850 | 3,520 |
| Operating Cash Flow | $-2,470 | $-2,670 | $-2,360 | $-2,620 | $-2,840 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -130 | -7 | 0 | -20 | 0 |
| Other Investing Activity | -30 | 187 | -220 | -10 | -60 |
| Investing Cash Flow | $-160 | $180 | $-220 | $-30 | $-60 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,100 | 1,330 | 5,120 | 0 | 5,080 |
| Financing Cash Flow | $2,100 | $1,330 | $5,120 | $0 | $5,080 |
| Beginning Cash Position | 1,590 | 2,740 | 210 | 2,870 | 700 |
| End Cash Position | 1,050 | 1,590 | 2,740 | 210 | 2,870 |
| Net Cash Flow | $-530 | $-1,150 | $2,530 | $-2,660 | $2,160 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,470 | -2,670 | -2,360 | -2,620 | -2,840 |
| Free Cash Flow | -2,470 | -2,670 | -2,360 | -2,620 | -2,840 |